opinion | Ron Wyden’s neutralization theory

A powerful Democratic senator calls on the FDA and Biden to ignore a potential court order…

Walgreens CEO Bets on Doctors Over Drugstores in Search for Growth

Rosalind Brewer is focusing the series on medical clinics.

Abbott Baby-Formula Business Is Under Investigation By SEC, FTC

Business The agencies are questioned amid a criminal investigation by the Justice Department into the company’s…

GE HealthCare Makes Push Into Artificial Intelligence

The company is developing a software platform that helps hospitals manage care.

Biogen Boss Turns Corner on Alzheimer’s Miscues

The biotech company needs to embark on a new growth path as former Sanofi CEO Chris…

Collecting Pharma’s Scraps Can Pay Off for This Biotech

Market heard on the street Roivant has created a unique model that allows it to take…

Exxon Is an Exile on Wall Street and Loving It

Market heard on the street The shake-up of the Dow Jones Industrial Average left Exxon Mobil,…

The End of AbbVie’s $200 Billion Monopoly Won’t Sink the Stock

The drugmaker is heavily discounting its immune-disease drug Humira to protect market share this year.

Mass Layoffs or Hiring Boom? What’s Actually Happening in the Jobs Market

By Sarah Chaney Cambon And ray a smith February 9th, 2023 8:01 am ET listen to…

CVS Makes $10 Billion Bet on Seniors

As profitability has plummeted despite government actions, CVS sees opportunity in expanding its Medicare Advantage business.